Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach

MBANYA, Jean; AL-SIFRI, Saud; ABDEL-RAHIM, Aly; Satman, İlhan

doi:10.1016/j.diabres.2015.04.030

Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach

MBANYA J. C., AL-SIFRI S., ABDEL-RAHIM A., Satman I.

DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.109, sa.2, ss.226-232, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Derleme
Cilt numarası: 109 Sayı: 2
Basım Tarihi: 2015
Doi Numarası: 10.1016/j.diabres.2015.04.030
Dergi Adı: DIABETES RESEARCH AND CLINICAL PRACTICE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.226-232
Anahtar Kelimeler: Ramadan, Diabetes, Gliclazide, GLUCOSE CONTROL, INSULIN SECRETAGOGUES, MUSLIM PATIENTS, DOUBLE-BLIND, SULFONYLUREA, VILDAGLIPTIN, SITAGLIPTIN, MANAGEMENT, MORTALITY, OUTCOMES
İstanbul Üniversitesi Adresli: Evet

Özet

Aim: Hypoglycemia can be a concern for patients with type 2 diabetes when fasting during Ramadan. In this analysis, we assessed the incidence of symptomatic hypoglycemic events in fasting patients treated with gliclazide or dipeptidyl peptidase-4 (DPP-4) inhibitors.